Hematology/Oncology Team Lead
Robert H. Lurie Comprehensive Cancer Center
Northwestern Memorial Hospital
This program has been made available online.
Slides from Clinical Care Options (CCO) with key findings on BTK inhibitors in CLL and MCL from the 2022 ASCO, EHA, Pan Pacific, ESMO, and SOHO meetings
Downloadable slideset from a local live webinar developed by lymphoma experts with guidance on the management of indolent lymphomas
Experts highlight key studies presented at the 2022 EHA annual meeting in this commentary from Clinical Care Options (CCO)
Updated data for epcoritamab + rituximab and lenalidomide in relapsed/refractory follicular lymphoma from EPCORE NHL-2, presented at ASCO 2022 and reported by Clinical Care Options (CCO)